Get the Stockscreener App
2.72
0.73%
-0.02
After Hours:
3.60
0.88
+32.35%
Serina Therapeutics Inc stock is traded at $2.72, with a volume of 6.00M.
It is down -0.73% in the last 24 hours and up +2.26% over the past month.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.
See More
Previous Close:
$2.74
Open:
$2.72
24h Volume:
6.00M
Relative Volume:
45.96
Market Cap:
$29.01M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-4.56%
1M Performance:
+2.26%
6M Performance:
-52.41%
1Y Performance:
-42.98%
1-Day Range:
$2.51
$2.72
1-Week Range:
$2.51
$3.06
52-Week Range:
$1.7101
$7.92
Serina Therapeutics Inc Stock (SER) Company Profile
Name
Serina Therapeutics Inc
Sector
Industry
Phone
(256) 327-9630
Address
601 GENOME WAY, HUNTSVILLE
Compare SER with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SER
Serina Therapeutics Inc
|
2.72 | 29.22M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.91 | 120.31B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
751.13 | 81.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
846.75 | 53.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
349.58 | 46.87B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
350.00 | 37.20B | 4.98B | 69.59M | 525.67M | 0.5197 |
Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-14-25 | Initiated | H.C. Wainwright | Buy |
Serina Therapeutics Inc Stock (SER) Latest News
Serina Therapeutics announces FDA clearance of IND application for SER-252 for the treatment of advanced Parkinson's disease - marketscreener.com
Serina Therapeutics Announces FDA Clearance of IND Application for SER-252 for the Treatment of Advanced Parkinson’s disease - The Manila Times
Serina Therapeutics, Inc. Announces FDA Clearance for SER-252 IND - TradingView
FDA clears trial of new advanced Parkinson’s therapy SER-252 - Stock Titan
New Highs: Why is Serina Therapeutics Inc stock going upJuly 2025 Update & Weekly Breakout Stock Alerts - baoquankhu1.vn
Serina Therapeutics CSO sells $7375 in shares By Investing.com - Investing.com Canada
Aug Technicals: Is Serina Therapeutics Inc benefiting from innovation trends2025 Biggest Moves & Daily Growth Stock Investment Tips - baoquankhu1.vn
Serina Therapeutics CSO sells $12,140 in shares By Investing.com - Investing.com India
Serina Therapeutics CSO sells $12,140 in shares - Investing.com
Geopolitics Watch: Why is Serina Therapeutics Inc stock going upTrade Risk Summary & Accurate Trade Setup Notifications - baoquankhu1.vn
Winners Losers: What is the dividend yield of Serina Therapeutics IncJuly 2025 Action & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Serina Therapeutics receives NYSE notification - MSN
Serina Therapeutics (SER) Receives NYSE Deficiency Notice for Low Stockholders' Equity - Intellectia AI
Serina Therapeutics Faces NYSE American Compliance Deficiency Notice - The Globe and Mail
Serina Therapeutics Receives NYSE Deficiency Notice; Stock Edges Down - Nasdaq
Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' Equity - The Globe and Mail
Serina Therapeutics receives NYSE listing deficiency notice - Investing.com
Serina Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Serina Therapeutics receives NYSE listing deficiency notice By Investing.com - Investing.com UK
Serina Therapeutics CSO Moreadith sells shares for $16,253 - Investing.com
Serina Therapeutics CSO Moreadith sells shares for $16,253 By Investing.com - Investing.com South Africa
What is the fair value of Serina Therapeutics Inc. stock nowJuly 2025 Selloffs & Weekly Market Pulse Updates - ulpravda.ru
Serina Therapeutics CSO Moreadith sells $34,953 in shares By Investing.com - Investing.com Canada
Serina Therapeutics (SER) Chief Scientific Officer reports 13,000-share sale - Stock Titan
Will Serina Therapeutics Inc. (2BO) stock split increase liquidityWide Width Options & walk-ready comfort choices - ulpravda.ru
Serina Therapeutics, Inc. Common Stock (NYSE:SER) Stock Quote - FinancialContent
Buybacks Report: How supply chain issues affect Serina Therapeutics Inc. stockQuarterly Profit Review & Technical Pattern Based Buy Signals - Улправда
Will Serina Therapeutics Inc. stock continue dividend increasesPortfolio Risk Report & Long Hold Capital Preservation Tips - Улправда
Why Serina Therapeutics Inc. stock attracts global investorsWeekly Trade Review & AI Forecast for Swing Trade Picks - ulpravda.ru
Is Serina Therapeutics Inc. (2BO) stock good for long term investingJuly 2025 Opening Moves & Capital Efficiency Focused Strategies - Улправда
How supply chain issues affect Serina Therapeutics Inc. stockTrade Performance Summary & Weekly Return Optimization Alerts - Улправда
Forecast Cut: How supply chain issues affect Serina Therapeutics Inc. stock2025 Momentum Check & Fast Gaining Stock Reports - Улправда
Can Serina Therapeutics Inc. (2BO) stock sustain breakout momentumTrade Signal Summary & Technical Confirmation Trade Alerts - Улправда
Is Serina Therapeutics Inc. stock gaining market shareMarket Risk Summary & Daily Risk Controlled Trade Plans - ulpravda.ru
Breakout Zone: Is Bolt Biotherapeutics Inc stock vulnerable to regulatory risksTrade Entry Report & Expert-Curated Trade Recommendations - moha.gov.vn
Growth Value: Why Serina Therapeutics Inc stock attracts global investorsWeekly Market Report & Consistent Income Trade Recommendations - moha.gov.vn
Published on: 2025-12-31 12:01:21 - bollywoodhelpline.com
Trade Recap: Can Serina Therapeutics Inc 2BO stock sustain breakout momentumQuarterly Market Summary & Accurate Technical Buy Alerts - moha.gov.vn
Serina secures additional $5 million for Parkinson's trial - MSN
Serina Therapeutics (SER) CSO exercises options and sells 4,100 shares - Stock Titan
Moreadith of Serina Therapeutics sells shares worth $15,167 By Investing.com - Investing.com India
Moreadith of Serina Therapeutics sells shares worth $15,167 - Investing.com
Serina Therapeutics CSO Sells Shares - TradingView — Track All Markets
Serina Therapeutics (SER) Chief Scientific Officer option exercise and share sale - Stock Titan
Aug Sectors: Why Serina Therapeutics Inc. stock is considered a top pickIPO Watch & Safe Capital Growth Plans - Улправда
Will Serina Therapeutics Inc. stock top growth indexes2025 Fundamental Recap & Community Verified Trade Alerts - Улправда
Why Serina Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Short Interest & Community Trade Idea Sharing - Улправда
Ideas Watch: Why Serina Therapeutics Inc. stock attracts global investors2025 Price Action Summary & Long-Term Capital Growth Ideas - moha.gov.vn
Is Serina Therapeutics Inc. stock cheap at current valuationJuly 2025 Volume & Short-Term Trading Alerts - Улправда
Will Serina Therapeutics Inc. stock deliver better than expected guidanceWall Street Watch & AI Powered Market Trend Analysis - DonanımHaber
Will Serina Therapeutics Inc. (2BO) stock sustain uptrend momentum2025 Stock Rankings & AI Forecast Swing Trade Picks - DonanımHaber
Serina Therapeutics Inc Stock (SER) Financials Data
There is no financial data for Serina Therapeutics Inc (SER). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
2.49%
4.12%
Cap:
|
Volume (24h):